Characteristic | Studied patients (n = 127) |
---|---|
Age (y) | 58.5 ± 9.9 |
Male sex (%) | 40.9 |
baPWV (cm/s) | 1767.2 ± 651.5 |
DM (%) | 23.6 |
Inradialytic hypotension (%) | 20.5 |
Always hypotension (%) | 3.9 |
HDF (%) | 16.5 |
Hb (g/dL) | 10.5 ± 1.3 |
BUN (mg/dL) | 64.7 ± 15.8 |
Cr (mg/dL) | 10.8 ± 2.4 |
Na (mEq/L) | 139.8 ± 3.1 |
K (mEq/L) | 4.8 ± 0.7 |
Calcium (mg/dL) | 9.8 ± 1.0 |
Phosphorous (mg/dL) | 4.6 ± 1.4 |
Calcium-phosphorous product (mg/dL)2 | 46.0 ± 16.3 |
Alb (g/dL) | 4.1 ± 0.3 |
Total cholesterol (mg/dL) | 185.3 ± 38.6 |
Triglyceride (mg/dL) | 211.86 ± 157.37 |
Ultrafiltration amount per dialysis session (L) | 2.3 ± 1.1 |
SBP (mmHg) | 139.2 ± 27.0 |
ABI | 1.0 ± 0.1 |
TBI | 0.7 ± 0.1 |
Body Mass Index (kg/m2) | 22.6 ± 3.5 |
iPTH (pg/mL) | 191.3 ± 219.2 |
Urea reduction rate | 0.8 ± 0.1 |
Kt/V | 1.8 ± 0.3 |
Net protein catabolic rate (g/day/kg body weight) | 1.2 ± 0.4 |
Aluminum (ng/mL) | 10 ± 8 |
Hemodialysis duration (months) | 72.5 ± 61.8 |
hsCRP (mg/L) | 4.7 ± 6.4 |
NO2 (ppb) | 22.9 ± 3.8 |
CO (ppm) | 0.6 ± 0.2 |
SO2 (ppb) | 6.9 ± 2.1 |
PM10 (ug/m3) | 57.9 ± 5.7 |
PM2.5 (ug/m3) | 31.8 ± 2.8 |
O3 (ppb) | 25.9 ± 2.9 |
NO (ppb) | 10.1 ± 7.8 |